ABC | Volume 114, Nº5, May 2020

Viewpoint Ferrari COVID-19 and Cardiovascular Diesease Arq Bras Cardiol. 2020; 114(5):823-826 1. Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, et al. Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology. 2020 Feb 21:200490. [Epub ahead of print]. 2. Ghinai I, McPherson TD, Hunter JC, Kirking HL, Christiansen D, Joshi K, et al. First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA. Lancet. 2020;395(10230):1137-44. 3. Phan T. Genetic diversity and evolution of SARS-CoV-2. Infect Genet Evol. 2020 Feb 21;81:104260. 4. ChanKW,WongVT,TangSCW.COVID-19:anupdateontheepidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease. Am J ChinMed. 2020Mar 13:1-26. [Epub ahead of print]. 5. American College of Cardiology. Coronavirus Disease 2019 (COVID-19) Provides Potent Reminder of the Risk of Infectious Agents [Internet], 2020 [citado 18 mar. 2020]. Disponível em: <https://www.acc.org/latest-in- cardiology/articles/2020/03/01/08/42/feature-coronavirus-disease-2019- covid-19-provides-potent-reminder-of-the-risk-of-infectious-agents>. 6. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020;7(1):11. 7. JOHNS HOPKINS. Coronavirus Resource Center. 2020. Disponível em: <https://coronavirus.jhu.edu/map.html >. Acessado em23 de Abril, 2020. 8. HolshueML,DeBoltC,LindquistS,LofyKH,WiesmanJ,BruceH,etal.Firstcaseof 2019novelcoronavirusintheUnitedStates.NEnglJMed.2020;382(10):929-36. 9. Raoult D, Zumla A, Locatelli F, Ippolito G, Kroemer G. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020 Mar 2. [Epub ahead of print]. 10. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Feb 7. [Epub ahead of print]. 11. Brasil.MinistériodaSaúde.PlataformaIntegradadeVigilânciaemSaúde.Notificação de casos de doença pelo coronavírus 2019 (COVID-19); 2020. [citado 18mar. 2020].Disponívelem: <http://plataforma.saude.gov.br/novocoronavirus/ >. 12. G1. Brasil tem3.313mortes e 49.492 casos de coronavírus, diz ministério. 2020. Disponível em: <https://g1.globo.com/bemestar/coronavirus/ noticia/2020/04/23/brasil-tem-3313-mortes-e-49492-casos-de- coronavirus-diz-ministerio.ghtml>. Acessado em 23 de Abril, 2020. 13. LivingstonE,BucherK.Coronavirusdisease2019 (COVID-19) in Italy. JAMA. 2020 Mar 17. [Epub ahead of print]. 14. Coronavirus latest: most infections and deaths are now outside China. Nature [Internet], 2020 [citado 18 mar. 2020]. Disponível em: <https://www.nature.com/articles/d41586-020-00154-w> . 15. Ng OT, Marimuthu K, Chia PY, Koh V, Chiew CJ, De Wang L, et al. SARS- CoV-2 infection among travelers returning from Wuhan, China. N Engl J Med. 2020;382(15):1476-8. 16. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. 17. Elkind MS, Harrington RA, Benjamin IJ. Role of the American Heart Association in the Global COVID-19 Pandemic. Circulation. 2020 Mar 17. [Epub ahead of print]. 18. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia inWuhan, China: a single- centered, retrospective, observational study. Lancet Respir Med. 2020 Feb 24. [Epub ahead of print]. 19. Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-42. 20. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. 21. PanhwarMS,KalraA,GuptaT,KolteD,KheraS,BhattDL,etal.Effectofinfluenza on outcomes in patients with heart failure. JACCHeart Fail. 2019;7(2):112-7. 22. Wu Q, Zhou L, Sun X, Yan Z, Hu C, Wu J, et al. Altered lipid metabolism in recoveredSARSpatientstwelveyearsafter infection.SciRep.2017;7(1):9110. 23. GuanWJ, Ni ZY, Hu Y, LiangWH, OuCQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28. [Epub ahead of print]. 24. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 Mar 5. [Epub ahead of print]. 25. Sociedade Brasileira de Cardiologia. SBC Informa. Infecção pelo Coronavírus 2019 (COVID-19); 2020. [citado 18 mar. 2020]. Disponível em: <http://www.cardiol.br/sbcinforma/2020/20200313- comunicado-coronavirus.html>. References Potential Conflict of Interest No potential conflict of interest relevant to this article was reported. Sources of Funding There were no external funding sources for this study. Study Association This study is not associatedwith any thesis or dissertationwork. Ethics approval and consent to participate This article does not contain any studies with human participants or animals performed by any of the authors. 825